Skip to content

The efficacy and safety of Shugan Wendan Decoction in the treatment of metabolic syndrome: a randomized controlled clinical trial

A Randomized Controlled Clinical Trial of Shugan Wendan Decoction in Treating Metabolic Syndrome

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004676
Enrollment
Unknown
Registered
2021-03-31
Start date
2021-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

control group:Conventional treatment

Sponsors

The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine (Guangdong Provincial Hospital of Traditional Chi
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of metabolic syndrome (2) It accords with the mutual accumulation of phlegm and blood stasis, and also clamps the syndrome of stagnation of the liver; (3) Aged between 18-75 years old; (4) Those who voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severe cardiovascular and cerebrovascular diseases (such as cardiac insufficiency, acute myocardial infarction, cerebral infarction, cerebral hemorrhage, etc.), liver and kidney insufficiency, mental disorders and other diseases; patients with severe complications such as type I diabetes or diabetic ketosis; (2) Those who are unwilling to cooperate with data collection and blood sampling; (3) Women during pregnancy or lactation; (4) Those who use insulin to control blood sugar (5) Other situations that the researcher thinks are not suitable for participating in this research.

Design outcomes

Primary

MeasureTime frame
Blood lipids;

Secondary

MeasureTime frame
TCM Syndrome Points;Insulin resistance index;Fasting blood glucose;Fasting insulin;Glycated hemoglobin;

Contacts

Public ContactCai hairong
286941768@qq.com17817399856

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026